NY S 10298
in committeeEnacts the "Terminate Excessive Cross-state Actuarial Subsidization (TEXAS) Act"
New York · 2025-2026 Regular Session · upper
Quick answers
Did NY S 10298 pass?
Not yet. NY S 10298 is in committee as of 2026-05-12 and has not come to a final vote. Latest recorded action (2026-05-12): REFERRED TO INSURANCE
What is NY S 10298 about?
Enacts the "Terminate Excessive Cross-state Actuarial Subsidization (TEXAS) Act" which requires life insurance companies to take state specific population health information into account as a factor; requires the superintendent of financial services to develop a standard weight to be given to state specific population health information in rate-setting.
Who sponsors NY S 10298?
James Skoufis is the primary sponsor of NY S 10298.
Description
Enacts the "Terminate Excessive Cross-state Actuarial Subsidization (TEXAS) Act" which requires life insurance companies to take state specific population health information into account as a factor; requires the superintendent of financial services to develop a standard weight to be given to state specific population health information in rate-setting.
- Introduced
- —
- Latest action
- 2026-05-12 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- James Skoufisprimary
Committees
Not provided by source.
Action timeline
2026-05-12
REFERRED TO INSURANCE
referral-committee
Versions
- S10298Compare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: A 11404
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 10298. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.